Traws Pharma's market cap is currently $24.57M. The company's EPS TTM is $-141.345; its P/E ratio is ―; Traws Pharma is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $-9.55. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 226.00K	$ 226.00K	$ 226.00K	$ 231.00K	$ 2.18M
Gross Profit	$ 210.00K	$ 212.00K	$ 212.00K	$ 231.00K	$ 2.18M
Operating Income	$ -20.30M	$ -19.63M	$ -16.50M	$ -24.99M	$ -21.70M
EBITDA	$ -20.28M	$ -19.61M	$ -16.48M	$ -24.98M	$ -21.68M
Net Income	$ -18.95M	$ -18.96M	$ -16.16M	$ -25.16M	$ -21.50M
Balance Sheet
Cash & Short-Term Investments	$ 20.82M	$ 38.76M	$ 55.07M	$ 19.02M	$ 22.73M
Total Assets	$ 22.68M	$ 39.37M	$ 55.48M	$ 19.99M	$ 23.67M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -20.82M	$ -38.76M	$ -55.07M	$ -19.02M	$ -22.73M
Total Liabilities	$ 12.01M	$ 11.06M	$ 9.36M	$ 13.81M	$ 12.10M
Stockholders' Equity	$ 10.67M	$ 28.31M	$ 46.12M	$ 6.17M	$ 11.57M
Cash Flow
Free Cash Flow	$ -17.95M	$ -16.29M	$ -19.49M	$ -23.09M	$ -20.89M
Operating Cash Flow	$ -17.93M	$ -16.29M	$ -19.49M	$ -23.07M	$ -20.83M
Investing Cash Flow	$ -14.00K	$ 0.00	$ 0.00	$ -15.00K	$ -55.00K
Financing Cash Flow	$ 0.00	$ 0.00	$ 55.56M	$ 19.36M	$ 26.65M

Currency in USD

Traws Pharma Earnings and Revenue History

Income Statement >

Traws Pharma Debt to Assets

Balance Sheet >

Traws Pharma Cash Flow

Cash Flow >

Traws Pharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing